| 12.79 1.09 (9.32%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 20.74 | 1-year : | 27.76 |
| Resists | First : | 17.76 | Second : | 23.77 |
| Pivot price | 16.29 |
|||
| Supports | First : | 8.03 | Second : | 6.68 |
| MAs | MA(5) : | 12.1 |
MA(20) : | 16.14 |
| MA(100) : | 11.35 |
MA(250) : | 8.43 |
|
| MACD | MACD : | 0.5 |
Signal : | 1.6 |
| %K %D | K(14,3) : | 12.8 |
D(3) : | 10.8 |
| RSI | RSI(14): 46.9 |
|||
| 52-week | High : | 44.56 | Low : | 3.69 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MEDS ] has closed above bottom band by 25.8%. Bollinger Bands are 24.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 14.86 - 14.94 | 14.94 - 15.02 |
| Low: | 12.13 - 12.23 | 12.23 - 12.31 |
| Close: | 12.65 - 12.79 | 12.79 - 12.92 |
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Fri, 26 Jul 2024
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - StockTitan
Wed, 17 Jul 2024
TRxADE HEALTH, Inc. (MEDS) To Go Ex-Dividend on July 19th - American Banking and Market News
Tue, 09 Jul 2024
TRxADE Health, Inc. Announces Special Cash Dividend - StockTitan
Wed, 26 Jun 2024
TRxADE: Q1 Earnings Snapshot - San Francisco Chronicle
Thu, 20 Jun 2024
TRxADE Health appoints new board member Subbarao Jayanthi - Investing.com
Fri, 10 May 2024
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 63.9 (%) |
| Held by Institutions | 10.2 (%) |
| Shares Short | 71 (K) |
| Shares Short P.Month | 10 (K) |
| EPS | -24.25 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.68 |
| Profit Margin | 52.4 % |
| Operating Margin | -153.7 % |
| Return on Assets (ttm) | -72 % |
| Return on Equity (ttm) | -269.4 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 5.51 |
| EBITDA (p.s.) | -8.47 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -11 (M) |
| Levered Free Cash Flow | -13 (M) |
| PE Ratio | -0.53 |
| PEG Ratio | 0 |
| Price to Book value | 1.32 |
| Price to Sales | 2.31 |
| Price to Cash Flow | -1.6 |
| Dividend | 1.5 |
| Forward Dividend | 0 |
| Dividend Yield | 11.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|